Analystreport

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at Roth Capital from $101.00 to $70.00.

Enanta Pharmaceuticals, Inc.  (ENTA) 
Last enanta pharmaceuticals, inc. earnings: 2/6 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.enanta.com/investor-overview